Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Pfizer’s dealmaking continues as GBT, Biohaven acquisitions close
Medical Marketing and Media
Wed, 10/5/22 - 10:43 am
Tags:
Pfizer, M&A, Global Blood Therapeutics, Biohaven
No big bang for biopharma buyouts
EP Vantage
Wed, 10/5/22 - 10:29 am
Tags:
M&A, Pfizer, Global Blood Therapeutics, Amgen, ChemoCentryx, Novo Nordisk, Forma, Alcon, Aerie Pharmaceuticals, Gilead Sciences, MiroBio
With Pfizer sale in the rearview, Biohaven veers toward Kv7 platform following late-stage trial fails, delays
Fierce Biotech
Tue, 10/4/22 - 11:45 pm
Tags:
Pfizer, Biohaven, migraines, epilepsy
Pfizer’s PARP inhibitor combo treatment passes primary endpoint — but details are slim
Endpoints
Tue, 10/4/22 - 11:06 am
Tags:
Pfizer, Xtandi, Talzenna, PARP inhibitors, Medivation, clinical trials, prostate cancer
Pfizer pulls trigger on Voyager gene therapy capsid deal, clearing it to fire TRACER at CNS disease
Fierce Biotech
Tue, 10/4/22 - 10:48 am
Tags:
Pfizer, Voyager Therapeutics, capsids, gene therapy
Alnylam's new Onpattro data raise fresh doubts in heart disease fight against Pfizer: analyst
Fierce Pharma
Mon, 10/3/22 - 11:41 pm
Tags:
Alnylam, Onpattro, Pfizer, ATTR-CM
Amid scrutiny around Europe's vaccine purchase, Pfizer CEO Albert Bourla pulls out of committee hearing
Fierce Pharma
Mon, 10/3/22 - 11:39 pm
Tags:
Pfizer, Albert Bourla, Pharma CEOs, COVID-19, Europe, vaccines
Real-time reviews for cell and gene therapies? Pfizer to FDA: Yes, please
Endpoints
Wed, 09/28/22 - 10:32 pm
Tags:
FDA, Pfizer, cancer, RTOR, oncology
Pfizer/BioNTech seek FDA nod for new COVID boosters for children
Yahoo/Reuters
Mon, 09/26/22 - 10:39 am
Tags:
Pfizer, BioNTech, COVID-19, FDA, vaccines, pediatric, boosters
Pfizer whittles down US donation deal as global COVID-19 vaccine demand slumps
Fierce Pharma
Sun, 09/25/22 - 02:11 pm
Tags:
Pfizer, vaccines, COVID-19
Months after exiting clinical hold, Pfizer readies to resume dosing in phase 3 gene therapy trial
Fierce Biotech
Fri, 09/23/22 - 10:50 am
Tags:
Pfizer, clinical trials, hemophilia A, gene therapy, FDA, giroctocogene fitelparvovec
EASD 2022 – Pfizer’s oral GLP-1s struggle for a therapeutic window
EP Vantage
Fri, 09/23/22 - 10:34 am
Tags:
Pfizer, EASD, danuglipron, diabetes
Pfizer to supply 6 million Paxlovid treatments to Global Fund
Axios
Thu, 09/22/22 - 10:30 am
Tags:
Pfizer, Paxlovid, COVID-19, Global Fund
Can This Tiny Biotech Take On Pfizer?
Motley Fool
Tue, 09/20/22 - 10:19 am
Tags:
Prometheus Biosciences, Pfizer, inflammatory bowel disease, PRA023
BioNTech's COVID vaccine sales are poised to slip, but the shot will remain a 'cash cow' in the long term: analysts
Fierce Pharma
Mon, 09/19/22 - 09:55 pm
Tags:
Pfizer, BioNTech, vaccines, COVID-19
Pfizer hit with racial discrimination lawsuit over minority fellowship program
Fierce Pharma
Sun, 09/18/22 - 10:33 pm
Tags:
Pfizer, racial discrimination, legal
Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms
Fierce Pharma
Fri, 09/16/22 - 10:54 am
Tags:
Sanofi, AstraZeneca, Pfizer, GSK, nirsevimab, Beyfortus, RSV
Pfizer/BioNTech, Moderna COVID vaccines backed for full approval in EU by EMA panel
Seeking Alpha
Fri, 09/16/22 - 10:48 am
Tags:
Pfizer, BioNTech, Moderna Therapeutics, EMA, CHMP, vaccines, COVID-19, Europe
Prometheus takes on Pfizer in inflammatory bowel diseases
EP Vantage
Fri, 09/16/22 - 10:11 am
Tags:
Prometheus Biosciences, Pfizer, PF-06480605, PRA023, inflammatory bowel disease
Striving for 2023 launch, Pfizer touts topline PhIII win for another mass market vaccine
Endpoints
Thu, 09/15/22 - 10:31 am
Tags:
Pfizer, vaccine, meningococcal disease, clinical trials, MenABCWY

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.